1810011O10Rik Activators

RICTOR Activators encompass a diverse array of chemical compounds that influence various signaling pathways, culminating in the enhancement of RICTOR's role within the mTORC2 complex. For instance, Insulin is a potent activator of the PI3K/AKT pathway, leading to the phosphorylation and activation of RICTOR within the mTORC2 complex, thus facilitating the phosphorylation of downstream targets such as AKT. Similarly, AICAR, through its activation of AMPK, initiates a cascade that suppresses mTORC1 while indirectly promoting mTORC2 activity, where RICTOR is essential. Resveratrol and Metformin both act through SIRT1 and AMPK respectively, ultimately leading to upregulated RICTOR function in the mTORC2 pathway. Pioglitazone, via PPARγ activation, and Prostaglandin E2, through EP4 receptor stimulation, both upregulate the PI3K/AKT signaling, enhancing RICTOR's activity in mTORC2.

RICTOR activators are a collection of compounds that target various intracellular mechanisms to enhance the function of RICTOR, a key component of mTORC2, which is involved in several critical signaling pathways, including the AKT pathway. Insulin, a primary activator, uses the PI3K/AKT pathway to phosphorylate and activate RICTOR, thereby enhancing the mTORC2 complex's kinase activity towards its substrates, which includes AKT. Compounds like AICAR and Metformin activate AMPK, which then negatively regulates mTORC1, a process that subsequently may upregulate RICTOR's function in mTORC2. Resveratrol achieves a similar outcome by activating SIRT1 and LKB1, leading to AMPK activation and a potential increase in RICTOR activity within the mTORC2 pathway.